John Snisarenko, COO, Oyster Point Pharmaceuticals, developed his interest in eye care at age 13, upon being fitted with contact lenses by an optometrist. 

That interest led him through positions with several eye care companies, and eventually to Oyster Point Pharma, which Snisarenko says has “a very unique approach to dry eye.”

In this episode of the OIS Podcast, Snisarenko talks with our host Paul Karpecki, OD, about building a startup, moving through a successful IPO, and getting to a position of having a product ready to commercialize such as Oyster Point has done with its nasal spray OC-01. He said, “Be prepared to roll up your sleeves, and sometimes you’re building the plane as you fly it.”

Snisarenko also talks about the importance of developing a good corporate culture, and says at Oyster Point two main credos are:

• Follow the science
• Think about the patient first

“If you do those two right,” he said, “Follow the science and really follow the patient journey, the other things fall into place.”

Click play to hear John Snisarenko share his experiences in the eye care industry, and how other innovators can apply what he has learned!